API Activity CAS 171228 -49-2 99% Posaconazole Powder for Antifungal
China API Activity CAS 171228-49-2 99% Posaconazole Powder for Antifungal, Find details about China Posaconazole Powder, Posaconazole Antibiotic from API Activity CAS 171228-49-2 99% Posaconazole Powder for Antifungal
Basic Info.
Model NO.
Frazer -Posaconazole
CAS No.
171228-49-2
Colour
White
Appearance
White Powder
Shelf Life
2 Years
Storage
Store in a Well-Closed Container Away From Moistur
Form
Powder
Delivery
Express 5-7 Days Arrive
Storage Temp.
-20°c Freezer
Melting Point
170-172°c
Grade
Pharmaceutical Grade
Usage
Orally Active Triazole Antifungal
Trademark
Xi′an Frazer Biotech Co., Ltd.
Transport Package
Foil Bag
Specification
1kg Per Foil Bag, 10 Bags Per Carton, 25 Kg Per Dr
Origin
China
Model NO.
Frazer -Posaconazole
CAS No.
171228-49-2
Colour
White
Appearance
White Powder
Shelf Life
2 Years
Storage
Store in a Well-Closed Container Away From Moistur
Form
Powder
Delivery
Express 5-7 Days Arrive
Storage Temp.
-20°c Freezer
Melting Point
170-172°c
Grade
Pharmaceutical Grade
Usage
Orally Active Triazole Antifungal
Trademark
Xi′an Frazer Biotech Co., Ltd.
Transport Package
Foil Bag
Specification
1kg Per Foil Bag, 10 Bags Per Carton, 25 Kg Per Dr
Origin
China
Product Desciption
High Quality Posaconazole CAS 171228-49-2 Noxafil for Antifungal
Product Name: Posaconazole
Synonyms: 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2-((2S,3S)-2-hydroxypentan-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one;4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorobenzyl)tetrahydrofuran-3;Posaconazole(Form );Posaconazole;2,5-Anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol;Noxafil;Sch 56592;HYDROXYPROPYL]-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE
CAS: 171228-49-2
MF: C37H42F2N8O4
MW: 700.78
EINECS: 682-747-8
Melting point: 170-172°C
Boiling point: 850.7±75.0 °C
Density: 1.36±0.1 g/cm3
Storage temp.: -20°C Freezer
Appearance: white to beige powder
Description:
Posaconazole, launched in the UK, is the newest member of the class of antifungal agents to reach the market. It is indicated for the treatment and prophylaxis of a range of invasive fungal infections, including aspergillosis,fusariosis, chromoblastomycosis, mycetoma, and coccidiomycosis in patients who are refractory to, or intolerant of, standard therapy with amphotericin B and/or itraconazole. In the US, it is approved for the prophylaxis of invasive Aspergillus and Candida infections in patients 13 years of age who are at high risk of developing these infections due to being severely immunocompromised. Additionally, it is approved for the treatment of oropharyngeal candidiasis. Posaconazole has an expanded spectrum of activity over other members of the antifungals. In addition to potent activity against refractory cases of aspergillosis and fluconazole-resistant Candida, it demonstrates activity against Zygomycetes.
Uses:
Orally active triazole antifungal.
Synonyms: 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2-((2S,3S)-2-hydroxypentan-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one;4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorobenzyl)tetrahydrofuran-3;Posaconazole(Form );Posaconazole;2,5-Anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol;Noxafil;Sch 56592;HYDROXYPROPYL]-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE
CAS: 171228-49-2
MF: C37H42F2N8O4
MW: 700.78
EINECS: 682-747-8
Melting point: 170-172°C
Boiling point: 850.7±75.0 °C
Density: 1.36±0.1 g/cm3
Storage temp.: -20°C Freezer
Appearance: white to beige powder
Description:
Posaconazole, launched in the UK, is the newest member of the class of antifungal agents to reach the market. It is indicated for the treatment and prophylaxis of a range of invasive fungal infections, including aspergillosis,fusariosis, chromoblastomycosis, mycetoma, and coccidiomycosis in patients who are refractory to, or intolerant of, standard therapy with amphotericin B and/or itraconazole. In the US, it is approved for the prophylaxis of invasive Aspergillus and Candida infections in patients 13 years of age who are at high risk of developing these infections due to being severely immunocompromised. Additionally, it is approved for the treatment of oropharyngeal candidiasis. Posaconazole has an expanded spectrum of activity over other members of the antifungals. In addition to potent activity against refractory cases of aspergillosis and fluconazole-resistant Candida, it demonstrates activity against Zygomycetes.
Uses:
Orally active triazole antifungal.
You Might Also Like
Low Cost 2-8mm Coffee Husk Hen Feed Press for Pakistan
Nice Design 90km Mileage Electric Scooter with Front Basket
A356 Aluminum Sand Casting Parts
3-Blade Aluminum Outboard Propeller
Mercedes Benz W639 Vito Viano Air Compressor 6393200204 6393......
Made in China Metal Zinc Alloy Soft Enamel Sport Medallion C......
10t 30t 40t Locosc Shear Beam Weighing Load Cell for Weighbr......
4.1kwh Lithium Battery Wall Mount LiFePO4 24V 160ah Deep Cyc......
A3 Size DTG Tshirt Jeans Jackets Printer for Dark Light Colo......
PVC Co-Extrusion Foam Board with Cheaper Price
Superior Popular Art Fineliner Drawing Pen with Water Proof ......